copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Edwards Lifesciences Corp - Overview Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most Learn More
Who we are - Edwards Lifesciences Through our actions, we will become trusted partners with customers, colleagues, and patients — creating a community unified in its mission to improve the quality of life around the world Our results will benefit customers, patients, employees, and shareholders We will celebrate our successes, thrive on discovery, and continually expand our boundaries We will act boldly, decisively, and
Locations - Edwards Lifesciences Headquartered in Irvine, California, our teams work together to create a sense of community and are focused on supporting what is best for Edwards and the patient Interested in a position at Edwards Lifesciences? We have opportunities around the world See where a career with Edwards could take you
Careers | Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most
Press Releases | Edwards Lifesciences TRISCEND II Trial Demonstrates Superior Clinical and Quality-of-life Benefits With Edwards EVOQUE System for Severe Tricuspid Regurgitation
Edwards Lifesciences to Sell Critical Care to BD IRVINE, CA-- (BUSINESS WIRE)-- Edwards Lifesciences (NYSE: EW) today announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company) (NYSE: BDX), in an all-cash transaction valued at $4 2 billion With this agreement, Edwards is no longer pursuing the previously announced spin-off of Critical Care Edwards will use the after
Newsroom - Edwards Lifesciences Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most